NKTR-255
19-255-03
Phase 2 small_molecule completed
Quick answer
NKTR-255 for Head and Neck Squamous Cell Carcinoma is a Phase 2 program (small_molecule) at NEKTAR THERAPEUTICS with 1 ClinicalTrials.gov record(s).
Program details
- Company
- NEKTAR THERAPEUTICS
- Indication
- Head and Neck Squamous Cell Carcinoma
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- completed